Primary Care Reports – January 1, 2024
January 1, 2024
View Archives Issues
Current trends in cannabinoid research, federal and state cannabis legislation, multi-sourced information, as well as misinformation, all drive consumer interest in cannabidiol (CBD). With the increased use of CBD products, increased incidents of poisonings are being reported. With confusion on policy, on potential benefits and harms, and on long-term chronic effects often seen with excessive use, determining the facts is increasingly problematic for healthcare practitioners and consumers. These issues prioritize the need for clinicians, especially in primary care, to stay current on developments related to CBD and other cannabinoids.